Expression and clinical significance of pepsinogen C in resectable pancreatic cancer

International Journal of Biological Markers

Volumn 16, Issue 1, 2001, Pages 31-36

  Truan, N ^a   Vizoso, F ^a   Fresno, M F ^a   Fernandez R ^a   Quintela, I ^a   Alexandre, E ^a   Martinez A ^a  

^a HOSPITAL DE JOVE   (Spain)

Author keywords

Pancreatic cancer; Pepsinogen C; Prognosis

Indexed keywords

BIOLOGICAL MARKER; PEPSINOGEN II;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; FEMALE; HORMONE RECEPTOR INTERACTION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; PANCREAS RESECTION; PANCREATICODUODENECTOMY; PROGNOSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; STOMACH FUNCTION; STOMACH MUCOSA; TREATMENT OUTCOME; TUMOR DIFFERENTIATION;

EID: 0035082333     PISSN: 03936155     EISSN: None     Source Type: Journal    
DOI: 10.1177/172460080101600104     Document Type: Article

References (37)

1. Cancer incidence and mortality in the European Union: Cancer registry data and estimates of national incidence for 1990
2. Pancreatic carcinoma
3. Cancer statistics
4. Human progastricsin. Analysis of intermediates during activation into gastricsin and determination of the amino acid sequence of the propart
5. Evolution in the structure and function of aspartic proteases
6. Cellular localization of the group II pepsinogens in human stomach and duodenum by inmunofluorescence
7. Identification of the acid proteinase in human seminal fluid as a gastricsin originating in the prostate
8. Differential distribution of pepsinogen II between the zones of the human prostate and the seminal vesicle
9. Isolation and characterization of a pepsin C zymogen produced by human breast tissues
10. Pepsinogen C expression in tumors of extragastric origin
11. Ovarian mucinous tumors frequently express makers of gastric, intestinal, and pancreatobiliary epithelial cells
12. Expression of pepsinogen II with androgen and oestrogen receptors in human prostate carcinoma
13. Expression of pepsinogen C in human breast tumors and correlation with clinicopathologic parameters
14. Pepsinogen C is a new prognostic marker in primary breast cancer
15. Immunoenzymatically determined pepsinogen C concentration in breast cytosols: An independent favourable prognostic factor in node-positive patients
16. The role of proteases in cancer
17. Tumor invasion and metastasis: An imbalance of positive and negative regulation
18. Hormonal regulation of the human pepsinogen C gene in breast cancer cells
19. Ductal cancers of the pancreas frequently express markers of gastrointestinal epithelial cells
20. Relationship between expression of gastrointestinal markers and survival in human pancreatic carcinoma
21. Histological and fine structural features of pancreatic ductal adenocarcinomas in relation to growth and prognosis: Studies in xenografted tumors and clinicohistopathologic correlation in a series of 75 cases
22. Production of antisera with small doses of immunogen: Multiple intradermal injections
23. Differentiation features of human pancreatic tumor cells maintained in nude mice and in culture: Immunocytochemical and ultrastructural studies
24. Expression of cathepsin E in pancreas: A possible tumor marker for pancreas, a preliminary report
25. Carcinoma of the exocrine pancreas: A sex hormone responsive tumour?
26. Effect of castration and hormone replacement on azasarine-induced pancreatic carcinogenesis in male and female Fisher rats
27. Inhibitory effects of estrogen and castration on the early stage pancreatic carcinogenesis in Fisher rats treated with azaserine
28. Dehydroepiandrosterone-sulfate inhibits pancreatic carcinoma cell proliferation in vitro and in vivo
29. Oral dehydroepiandrosterone inhibits the growth of human pancreatic cancer in nude mice
30. A prospective randomised controlled trial of tamoxifen and cyproterone acetate in pancreatic carcinoma
31. Clinical trial of tamoxifen in patients with irresectable pancreatic adenocarcinoma. The Yorkshire Gastrointestinal Tumour Group
32. Survival benefit of tamoxifen therapy in adenocarcinoma of pancreas. A case-control study
33. Effect of flutamide on survival in patients with pancreatic cancer: Results of a prospective, randomised, double blind, placebo controlled trial
34. Androgen receptor in human normal and malignant pancreatic tissue and cell lines
35. Is exocrine pancreatic cancer a hormone dependent tumor?
36. Expression of oestrogen receptor and oestrogen-inducible genes in pancreatic cancer